CoChat

Role of AHR and HIF-1α in Glioblastoma Metabolism

Open access
Gabriely, Galina, Wheeler, Michael A., Takenaka, Maisa C., Quintana, Francisco J. · 2017 · Trends in Endocrinology & Metabolism
Cited by 123

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Glioblastoma (GBM) progression is associated with metabolic remodeling in both glioma and immune cells, resulting in the use of aerobic glycolysis as the main source energy and biosynthetic molecules. The transcription factor HIF-1α drives this metabolic reorganization. Oxygen levels as well as other factors control the activity of HIF-1α. In addition, the ligand-activated transcription factor AHR modulates tumor-specific immunity and can also participate in metabolic remodeling. AHR activity is regulated by tryptophan derivatives present in the tumor microenvironment. Thus, the tumor microenvironment, signaling via HIF-1α and AHR, regulates the metabolism of gliomas and immune cells, modulating tumor-specific immunity and consequently, tumor growth. Here, we will review the roles of HIF-1α and AHR in cancer and immune cell metabolism in glioblastoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tem.2017.02.009

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 123

Metadata

Authors
Gabriely, G., Wheeler, M. A., Takenaka, M. C., & Quintana, F. J.
Venue
Trends in Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2017-06
Volume
28
Issue
6
Pages
428-436
ISSN
1043-2760 (ISSN-L)
OpenAlex
W2596054013
Cited by
123
References
37
FWCI
1.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.